In previous studies on STZ-treated diabetic mice, glomerular complement component 3a (C3a) receptor 1 (C3aR) expression was observed in the early phase of DN, suggesting the pathological role of C3a in DN development [35]. This evidence concerns the gene C3AR1 and liver dysplastic nodule.